VermontBiz A first-of-its-kind initiative, funded by a National Institute on Drug Abuse grant, will conduct an ambitious ...
Analysts say the two new indications should help Eylea HD as Regeneron battles for market share with Roche’s Vabysmo.
Burlington Free Press on MSN
UVM joins major study on drug use and treatment barriers across New England
The initiative, funded by a $12 million grant from the National Institute on Drug Abuse, will evaluate how people with ...
Packaging Gateway on MSN
Zydus Lifesciences selects SIG for single-serve medicine pouches
India's Zydus Lifesciences has teamed up with SIG to launch its liquid cough and cold medicine in single-serve spouted ...
A MOTHER has revealed that she took the ‘golden dose’ of Mounjaro and is now urging others to not make the same mistake. Kate ...
Officials in L.A. initially ruled the death of 18-year-old Amelia Salehpour an accidental overdose. But her family has spent ...
Skip the gimmicks. These 10 smart, real-life lifesavers make feeding, changing, soothing and getting out the door simpler so ...
The ruling by reimbursement authority NICE means that Amvuttra (vutrisiran) can be used to treat wild-type or hereditary ATTR ...
To put this spike into perspective, the rural city of around 32,000 people has now recorded more HIV cases in two years than ...
GlobalData on MSN
Alvotech and Advanz announce EC approval for Gobivaz biosimilar
Alvotech and Advanz Pharma have announced EC marketing authorisations for Gobivaz, a biosimilar to Simponi, across the EEA.
Now imagine swapping some of that hardware for medicated skin cream that never pokes your skin. That is the vision behind a new Nature study describing a polymer that can haul insulin straight through ...
SIG and Zydus Lifesciences will distribute liquid cough and cold medication in single-serve, tethered spouted pouches - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results